ATE333880T1 - Montirelin zur verhinderung der schlafapnoe - Google Patents

Montirelin zur verhinderung der schlafapnoe

Info

Publication number
ATE333880T1
ATE333880T1 AT96936996T AT96936996T ATE333880T1 AT E333880 T1 ATE333880 T1 AT E333880T1 AT 96936996 T AT96936996 T AT 96936996T AT 96936996 T AT96936996 T AT 96936996T AT E333880 T1 ATE333880 T1 AT E333880T1
Authority
AT
Austria
Prior art keywords
pct
sleep apnea
montirelin
date
prevent sleep
Prior art date
Application number
AT96936996T
Other languages
English (en)
Inventor
Andrew Winokur
Allan I Pack
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of ATE333880T1 publication Critical patent/ATE333880T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT96936996T 1995-10-24 1996-10-24 Montirelin zur verhinderung der schlafapnoe ATE333880T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US603295P 1995-10-24 1995-10-24

Publications (1)

Publication Number Publication Date
ATE333880T1 true ATE333880T1 (de) 2006-08-15

Family

ID=21718957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96936996T ATE333880T1 (de) 1995-10-24 1996-10-24 Montirelin zur verhinderung der schlafapnoe

Country Status (12)

Country Link
US (1) US5968932A (de)
EP (1) EP0866711B1 (de)
JP (1) JPH11515015A (de)
AT (1) ATE333880T1 (de)
AU (1) AU714270B2 (de)
CA (1) CA2235854A1 (de)
DE (1) DE69636393T2 (de)
DK (1) DK0866711T3 (de)
ES (1) ES2268712T3 (de)
HK (1) HK1015283A1 (de)
PT (1) PT866711E (de)
WO (1) WO1997015309A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69829202T2 (de) * 1997-11-14 2005-07-21 Akzo Nobel N.V. Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
DE10025949A1 (de) * 2000-05-26 2001-11-29 Gruenenthal Gmbh Arzneimittel zur Bekämpfung von Atemdepression
DE102004010516A1 (de) * 2004-03-04 2005-09-22 Bayer Technology Services Gmbh Verbessertes Verfahren zur zeitlichen Dosierung von Arzneistoffen
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
US10042980B2 (en) 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20080086338A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20080086339A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
BR112020015316A2 (pt) 2018-01-30 2020-12-08 Apnimed, Inc. (Delaware) Métodos e composições para o tratamento da apneia do sono
JP2023520455A (ja) * 2020-04-02 2023-05-17 アプニメッド，インコーポレイテッド（デラウェア） 睡眠時無呼吸を治療するための方法および組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE408300B (sv) * 1974-10-16 1979-06-05 Gruenenthal Chemie Sett att framstella nya dipeptidderivat

Also Published As

Publication number Publication date
ES2268712T3 (es) 2007-03-16
AU714270B2 (en) 1999-12-23
EP0866711A4 (de) 2003-04-16
CA2235854A1 (en) 1997-05-01
DE69636393D1 (de) 2006-09-07
HK1015283A1 (en) 1999-10-15
WO1997015309A1 (en) 1997-05-01
AU7477096A (en) 1997-05-15
EP0866711A1 (de) 1998-09-30
DE69636393T2 (de) 2006-12-07
DK0866711T3 (da) 2006-11-27
EP0866711B1 (de) 2006-07-26
PT866711E (pt) 2006-12-29
JPH11515015A (ja) 1999-12-21
US5968932A (en) 1999-10-19

Similar Documents

Publication Publication Date Title
FI954609A (fi) 1-amidinofenyyli-pyrrolidoneja, -piperidinoneja ja -atsetinoneja verihiutaleiden kasaantumisen inhibiittoreina
DE69417733T2 (de) Verfahren zur hemmung des knochenschwundes mit 3,4-diarylchroman
ES2176235T3 (es) Pirazolitriazinas con actividad inhibidora de la interleuquina-1 y delfactor de necrosis tumoral.
DE69635459D1 (de) Acetylcholinesteraseinhibitoren zur behandlung und diagnose von atemstörungen während des schlafes
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
ATE189601T1 (de) Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen
ATE333880T1 (de) Montirelin zur verhinderung der schlafapnoe
GB9317636D0 (en) Use of dexmedetomidine
BR9509975A (pt) Formulação farmacêutica
DE69612510D1 (de) Verwendung von 1-(2-naphtylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode
DE69706382D1 (de) Verfahren zur herstellung von 2,2'-bipyrrolyl-pyrromethen-derivaten (prodigiosine)
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
MXPA04003631A (es) Rosuvastatina en estados de pre-demencia.
ATE240101T1 (de) Verwendung von 2-phenyl-3- aroylbenzothiophenderivaten zur herstellung eines medikaments zur knochen- und bruchheilung
SG42910A1 (en) Benzopyrans
DE69630876D1 (de) Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
ATE179890T1 (de) Verwendung von benzothiophenen zur herstellung eines medikaments zur verminderung der narbenbildung bei der wundheilung
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
DE69832796D1 (de) Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen
MX9702853A (es) Metodos para inhibir condiciones asociadas con el neuropeptido "y".

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0866711

Country of ref document: EP

REN Ceased due to non-payment of the annual fee